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Abstract
Increasing evidence suggests that activated erk regu-
lates cell functions, at least in part, by mechanisms that
do not require gene transcription. Here we show that the
map kinase, erk, decorates microtubules (MTs) and
mitotic spindles in both parental and mutant active ras-
transfected 10T1 /2 fibroblasts and MCF10A breast
epithelial cells. Approximately 20% of total cellular erk
decorated MTs in both cell lines. A greater proportion of
activated erk was associated with MTs in the presence
of mutant active H-ras than in parental cells. Activation
of erk by the ras pathway coincided with a decrease in
the stability of MT, as detected by a stability marker. The
MKK1 inhibitor, PD98059 and transfection of a dominant
negative MKK1 blocked ras- induced instability of MTs
but did not modify the association of erk with MTs or
affect MT stability of the parental cells. These results
indicate that the subset of active erk kinase that
associates with MTs contributes to their instability in
the presence of a mutant active ras. The MT-associated
subset of active erk likely contributes to the enhanced
invasive and proliferative abilities of cells containing
mutant active H-ras. Neoplasia (2001) 3, 385–394.
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Introduction
Microtubule (MT) reorganization and functional special-
ization is required for the cellular remodeling that occurs
during proliferation, migration, and invasion of normal and
cancer cells [1–6]. Drugs that hyperstabilize MTs, such as
paclitaxel, can block the progress of cells through mitosis
and have been reported to inhibit the invasion of breast and
ovarian cancer cells [7–9]. The initial clinical success of
reagents such as paclitaxel has focused attention on the
extracellular factors and signaling cascades that regulate the
stability and turnover of MTs during the transformation
process.
Microtubule-associated proteins (MAPs), such as tau
and MAP-1, bind directly to tubulin and are members of a
group of proteins that regulate MT stability. They promote
both the polymerization of tubulin and the stability of MTs by
reducing disassembly rate [10]. The ability of MAPs to bind
to tubulin is controlled, in part, by posttranslational mod-
ification including serine threonine phosphorylation [11].
Cdc2, MARKs, erk, and GSK-3 [12–14] kinases have been
shown to phosphorylate MAPs in vitro and to modify MAP-
mediated MT polymerization in vitro [11–14]. However, the
role that kinases play in determining MT dynamics in vivo has
not been well studied.
Recently, erk, has been shown by several groups to
decorate interphase MTs [15–18] and to associate with the
kinetochore of the mitotic spindle in vivo [19]. Erk also
associates with dynamic structures, such as focal adhe-
sions, that are associated with the actin cytoskeleton [20].
Ras, which can activate erk [24,26–28], has previously
been reported to promote cytoskeletal remodeling and to
contribute to highly dynamic processes such as vesicular
transport and cell motility [21,22]. Several studies have
shown that erk kinase activity results in disassembly of
actin stress fibers [15,23]. However, little is known about
the role of erk–MT associations in MT function in vivo [19].
Erk is predicted to contribute to the dynamic instability of
MT subsets because it phosphorylates both MAPs in vitro
[24,25] as well as proteins such as stathmin that are
involved in MT turnover [26].
Because of the role of MTs in proliferative, motile, and
invasive processes [6–9], and recent studies linking erk
and its upstream activator kinase MKK1 [27–29] to breast
cancer progression, we have assessed the role of the ras–
erk cascade in regulating MT stability both in fibroblasts
and in breast epithelial cells. A CIRAS-3 fibroblast line was
derived from the stable transfection of H-ras into 10T1/2
cells, which show lung colonization that is indicative of
highly metastatic cells [30]. The MCF10aNeo breast
epithelial cells were transformed with a mutant H-ras
oncogene, which has served as a model for the study of
the early stages of breast cancer [31]. We show that erk
kinase is required for dynamic MT turnover in both cell
backgrounds in the presence of mutant active ras but not in
parental cells.
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Materials and Methods
Antibodies and Other Reagents
Monoclonal anti–acetylated  - tubulin (6-11B-1), anti–
 - tubulin (B-5-1-2), and anti–active erk antibody (clone
MAPK-YT) were purchased from Sigma Chemical (St.
Louis, MO). An antipan-erk polyclonal antibody was
purchased from Transduction Laboratories (Lexington, KY)
and an anti–HA polyclonal antibody (HA.11) was purchased
from BaBCO (Richmond, CA). Secondary antibodies,
polyclonal FITC/TRITC-conjugated goat anti -mouse or
anti - rabbit secondary antibodies, were purchased from
Jackson ImmunoResearch Laboratories (West Grove, PA)
and HRP-conjugated donkey anti -mouse and anti - rabbit
antibodies were purchased from BioRad (Hercules, CA).
DMEM and F12 media were purchased from Gibco-BRL
(Burlington, ON, Canada); and fetal bovine and equine
serum, from Hyclone (Logan, UT) and Gibco-BRL, respec-
tively. All other reagents, unless otherwise indicated, were
purchased from Sigma.
Cell Culture
Human breast cancer cells MCF10aNeo (transfected
with neomycin vector ) and MCF10a-H-ras ( transfected
with T24-Ha-ras oncogene), obtained from Dr. C. J. Der
(University of North Carolina, Chapel Hill, NC), were
grown in supplemented DMEM/F12 (1:1) media with 5%
equine serum, as described [31]. The 10T1/2 and
CIRAS-3 (10T1/2-H-ras) transfected murine fibroblasts,
kindly donated by Dr. S. Egan (The Hospital for Sick
Children, Toronto, ON, Canada), were cultured in DMEM
containing 10% fetal calf serum. Mitotic cells were
enriched by the treatment of sparse cell cultures with
0.03 g/ml nocodazole (Sigma) for 12 to 16 hours in
growth medium. For all other experiments, equivalent cell
numbers of each cell type were plated for 8 hours in
growth medium to allow attachment to the substratum,
then cells were serum-starved for 18 hours in serum-free
medium. For immunofluorescence, 1104 cells were
plated on glass coverslips in six-well plates. For Western
blot analysis, 1105 cells were plated onto 150-mm
tissue-culture plates. For analysis of erk activity and MT
stability, cells were pretreated with 50 m of the MKK
inhibitor PD 98059 (Calbiochem Biosciences, Missis-
sauga, ON, Canada) for 2 hours, then stimulated with
10% serum in the presence of PD 98059 for 2 hours [32].
Controls received DMSO carrier alone, followed by serum
stimulation.
Preparation of MT Fraction
The MT cytoskeleton was enriched, as described [33], for
indirect immunofluorescence studies and Western blot
analyses. Soluble proteins were extracted by two consec-
utive 5-minute treatments of cells with 0.2% Triton X-100 in
MT-stabilizing buffer [0.1 M PIPES (pH 6.9), 1 mM EGTA,
2.5 mM GTP, 4% PEG 6000] supplemented with protease
and phosphatase inhibitors [33]. For immunofluorescent
studies, these extracted cells were fixed as described in the
next section. For Western blot analysis, the remaining
cytoskeletal and nuclear matrix was scraped off the plate
into 300 l /plate TBST [10 mM Tris (pH 7.5), 150 mM NaCl,
0.2% Triton X-100, 10 mM EDTA, 50 mM  -glycerophos-
phate, 1 mM Na3VO4, 1 mM microcystin LR, 2 g/ml
leupeptin, 1 g/ml aprotinin, 200 g/ml PMSF]. The
collected fraction was chilled on ice for 1 minute to
depolymerize MTs, vortexed, and then centrifuged to
separate the nuclear matrix and intermediate filament-
containing fraction [33]. The supernatant containing the
MT-enriched fraction [15] was then analyzed with Western
blots.
Western Blot Analysis
For analysis of total cell lysates, monolayer cultures
containing equal cell numbers were washed with phos-
phate-buffered saline (PBS) and then lysed in a 300 l /
plate RIPA buffer containing protease inhibitors, as
described [33]. Laemmli buffer was added to the cell
lysates and to the MT-enriched fractions, prepared as
described above; these were then boiled and loaded
equally by volume and separated by electrophoresis on a
10% SDS-PAGE gel, with prestained molecular weight
standards (Sigma). Separated proteins were transferred to
nitrocellulose membranes. Blots were blocked in TBST
containing 5% defatted milk on a gyrating shaker for 3
hours. Primary and secondary antibodies were diluted to 1
g/ml in TBST with 1% milk, and were incubated with blots
for 3 hours and 1 hour, respectively. Immunodetection of
bound antibody was done with secondary antibodies
conjugated to HRP (1 g/ml) and visualized with ECL
(Amersham Pharmacia Biotech, Piscataway, NJ), accord-
ing to the protocol of the supplier.
Transient Transfections
H-ras–transformed cells were transiently transfected
with 1 g of a pMCL-HA–tagged dominant negative
(K97M) form of MKK plasmid DNA [34] with the Lipofectin
reagent (Life Technologies, Gaithersburg, MD). Cells were
washed twice in defined medium after a 4-hour treatment,
then allowed to recover for 24 hours in growth medium (10%
fetal calf serum) before being processed for immunofluor-
escence, as described below.
Indirect Immunofluorescence
For immunofluorescent analyses, subconfluent cells
were washed with PBS, fixed with buffered 3% parafor-
maldehyde, and then permeabilized with 0.1% Triton X-
100 in PBS (PBST). Fixed cells were incubated for 1 hour
with PBS containing 3% bovine serum albumin (BSA) to
block nonspecific binding sites, then incubated with primary
antibodies diluted to 10 g/ml in 1% BSA/PBS for 2 hours.
Cells were washed with BSA/PBST and incubated with
fluorochrome-conjugated secondary antibodies (10 g/ml)
in the same buffer, then washed before coverslips were
mounted on glass slides with Vectashield (Vector Labo-
ratories, Burlington, CA) mounting media. Cells were
examined with a Zeiss Axiovert 100 M confocal LSM510
386 Erk Controls Microtobule Stability In Vivo Harrison and Turley
Neoplasia . Vol. 3, No. 5, 2001
microscope at constant laser settings. Mitotic cells were
mounted with Vectashield containing DAPI (1.5 g/ml)
and examined with epifluorescence on a Nikon Eclipse
E1000 microscope.
Densitometry Analysis
Quantitative evaluation of optical densities of the reactive
protein bands in Western blot analysis was done with NIH
Image (Scion Image 1.62a). Protein bands were analyzed
from replicate experiments after ECL and exposure of blots
at equal time points to autoradiographic film. The calculation
for relative amounts of active erk and acetylated  - tubulin in
whole cell lysates from equal cell numbers was normalized to
total erk and total  - tubulin, respectively. Active erk in MT-
enriched fractions was normalized to total erk or to total
active erk and to tubulin yield after extraction. Acetylated  -
tubulin levels after extraction were normalized to total  -
tubulin. Unless otherwise stated, blots were representative of
three independent assays. Data from each experiment were
pooled and expressed as mean±SD. Statistical analysis was
done with a two- tailed Student’s t test, where P<.05 was
considered significant.
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Figure 1. Stable transfection of fibroblasts and epithelial cells with mutant H - ras results in an increase in the percentage of active erk found in total erk protein levels.
(A ) Active erk and total cellular erk levels assayed byWestern blot analysis of cell lysates fromMCF10aNeo, MCF10a -H - ras, parental 10T1 / 2, and 10T1 /2 -H - ras
cells. Total erk protein levels slightly increased in the presence of a mutant H - ras whereas active erk levels increased by approximately two - fold compared with
parental cells after serum stimulation, as detected by densitometry analysis of replicate Western blot analyses in both human breast epithelial cells ( asterisks,
P< .007 and .002, for active erk 1 and 2, respectively ) and murine 10T1 /2 fibroblasts (asterisks, P< .01 and .004 for active erk 1 and 2, respectively ), relative to
vector - control cells (B ). Blots shown here are representative of three independent experiments.
Early telophase Late telophaseAnaphase
Figure 2. Anti –acetylated  - tubulin antibody detects stable MT subsets. Immunofluorescence of MCF10aNeo cells with the anti –acetylated  - tubulin antibody
and DAPI confirm that the tubulin posttranslational modification detected by this antibody is associated with the presence of stable MT subsets in interphase (A,
arrows ) and during mitosis (B–F, arrows ). Thus, staining is restricted to stable MT structures such as centrosomes (B ), spindle poles (C ), polar MTs (D and E ),
and midbodies (F ) during cell division ( bars, 10 m).
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Results
Cells transfected with mutant active ras express two- fold
more activated erk kinase and MTs are less stable, as
detected by a stability marker. For these studies, we used
mutant H-ras–transfected and parental human epithelial
cells and murine fibroblasts, and compared the levels of erk
protein expression and activation (Figure 1 ). The level of
erk protein expression was slightly higher in both H-ras–
transfected cells lines than in parental cells (Figure 1A ) but
the proportion of activated erk 1 and 2 kinases, stand-
ardized to total cellular erk 1 and 2, was approximately
two- fold higher in both the H-ras–transfected breast
epithelial and fibroblast cells (Figure 1;A and B ). To begin
to assess the role of erk kinase in MT stability of these cell
lines, we used a marker for MT stability that detected
posttranslational modification of tubulin subunits
[14,35,36]. We confirmed that this marker detected the
stable interphase MT of confluent 10T1/2 fibroblasts but
not the highly dynamic MTs of late telophase (Figure 2 )
[35]. Prominent acetylated MT arrays were observed in
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Figure 3. Stable transfection of fibroblasts and breast epithelial cells with mutant active H - ras results in a significant decrease in acetylated MTs. (A ) Indirect
immunofluorescence of MCF10a cells stably transfected with vector alone, or H - ras, parental murine 10T1 /2 fibroblasts, and 10T1 / 2 cells transfected with H - ras,
by means of an anti –acetylated  - tubulin antibody. Confocal analysis at constant laser settings show fewer acetylated MTs in both H - ras– transfected cell types,
compared with parental cells ( bar, 30 m), an observation that was confirmed by Western blot analysis of cell lysates (B ). The Western blots shown here are
representative of four independent assays. (C ) Densitometry analysis of Western blots quantifying the reduced acetylated  - tubulin protein in H - ras– transfected
cells ( asterisks; P< .012 and .006, respectively ). Acetylated  - tubulin levels were normalized to total  - tubulin levels for each cell type.
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interphase MCF10aNeo and 10T1/2 cells (Figure 3A ).
However, at constant confocal laser settings, a visible
decrease in acetylated MTs was seen in H-ras–trans-
fected MCF10a and embryonic 10T1/2-H-ras cells (Figure
3A ). These results suggest that MTs are less stable in both
H-ras–transfected cell types. This observation is consis-
tent with previous observations [27] showing that MTs of
H-ras–transfected fibroblasts were short and poorly
organized, characteristics typical of MTs with a high
turnover. To quantify the difference in acetylation of tubulin
among the cell lines, tubulin was separated from other
proteins in cell lysates using SDS-PAGE and the degree of
acetylation of tubulin subunits was detected in Western
blots using the anti–acetylated tubulin antibody. As shown
in Figure 3;B and C, levels of acetylated tubulin, normal-
ized to total  - tubulin, were significantly lower in both the
H-ras–transfected MCF10A breast epithelial cells and in
the H-ras–transfected 10T1/2 fibroblasts.
Erk Colocalizes with MTs in Human-Breast Epithelial Cells
and Murine Fibroblasts
Erk has previously been reported to decorate interphase
MTs in nontransformed cells, including macrophages,
neurons, and NIH 3T3 fibroblasts [15]. Erk has also been
shown to associate with the kineticore of the mitotic spindle
of NIH 3T3 fibroblasts [19]. We assessed whether human
breast epithelial and murine embryonic cells exhibited a
similar codistribution of erk with interphase and mitotic MTs
tubulin erk merge
A
B
C
D
Figure 4. Erk colocalizes with extracted MTs in both breast epithelial cells and murine fibroblasts. These three -dimensional reconstructions of confocal images
show representative attached interphase cells after double immunofluorescence with a pan - - tubulin monoclonal antibody and a pan -erk polyclonal antibody after
the removal of the cytosol and preservation of MTs. (A ) MCF10aNeo, (B ) MCF10a -H - ras, and (C ) 10T1 /2 -H - ras interphase cells. (D ) MCF10a -H - ras mitotic
cell. Colocalization of MTs and erk in both epithelial and fibroblast cell types was observed (bars, 25 m).
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and also assessed whether mutant active ras modified this
association. Cells were extracted in a detergent containing
buffer to remove the cytosol and to preserve MTs [33]. The
MTs were fixed and examined by double immunofluores-
cence for erk and  - tubulin distribution. Extensive colocal-
ization of erk with MTs was observed in both H-ras–
transfected and parental cell lines in interphase (Figure
4;A C ) and mitosis (Figure 4D ). These results confirmed
that erk associated with MTs independent of the cell
backgrounds and that this association was maintained in
the presence of mutant active ras.
H-ras–Transfected Cells Have Higher Levels of MT-Bound
Active Erk than Parental Cells
To quantify the amount of active erk associated with
MTs, we separated an MT-enriched fraction from the
nuclear and intermediate filament fraction, as previously
described using parental and H-ras–transfected MCF10A
breast epithelial cells [33]. This technique removed most
other cytoskeletal components and preserved MTs and
bound proteins [33]. A pan- - tubulin antibody confirmed
that MTs were abundant in this fraction (Figure 5A ).
Densitometry analysis of replicate Western blot analyses
revealed a slight increase in MT-associated total erk
protein in H-ras–transfected MCF10 A over that in parental
cells, even though total erk 1 and 2 protein expression of
these two cell types is similar (Figures 1A and 5A ). H-ras–
transfected MCF10a cells exhibit two- to three- fold higher
levels of MT-associated activated erk 1 and 2 kinase than
parental cells (Figure 5A ) when values were normalized to
total MT-associated erk, a ratio similar to that observed for
total cellular activated erk kinase in these cell lines (Figure
1A ). The percentage of total erk in the MT-enriched
fraction ranged from 15% to 25%, in both the ras-
transfected and control cells, comparable to reports for
other cell lines [15–17]. The MT fraction of ras- transfected
and parental cell lines were also compared for acetylated
 - tubulin levels. The amount of acetylated  - tubulin,
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Figure 5. H- ras– transfected cells exhibit increased levels of MT -associated active erk. (A ) RepresentativeWestern blot analysis of active erk, total erk, acetylated
 - tubulin, and total  - tubulin present in the MT-enriched fraction of MCF 10aNeo and MCF10a -H - ras cells. (B ) Densitometry analysis of replicate Western blot
experiments typified by (A ) reveal that H - ras– transfected MCF10a cells have a significantly higher ( approximately three - fold ) ratio of active erk to total erk protein,
associated with polymerized MTs than MCF10aNeo cells ( asterisks, P< .015 and .008 for active erk 1 and 2, respectively ). These values were normalized to a total
 - tubulin yield after extraction. (C ) A higher amount of active erk is associated with MTs in ras - transformed cells ( 25% to 28%) than with vector - control cells
( 19%) when MT-associated active erk levels are compared with total cellular active erk levels ( see ), representing about a 35% increase in active erk levels. (D )
Densitometry of the acetylated and total  - tubulin protein bands in (A ) show that the isolated polymerized MT subsets in H - ras– transfected cells have significantly
lower levels of acetylated  - tubulin in proportion to total  - tubulin than parental control cells when soluble tubulin is extracted ( asterisks; P< .03 and .047 for
MCF10a and 10T1 /2, respectively ). Blots shown here are representative of three independent experiments.
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normalized to total  - tubulin, was significantly less in the
ras- transfected cells than in the empty vector - transfected
cells (Figure 5D , asterisks ), confirming results shown in
Figure 1 where no attempt was made to isolate MT.
Inhibition of Erk Activation Enhances MT Stability in
H-ras–Transfected Cells
To assess whether association of active erk with MTs was
directly linked to the significantly decreased acetylated MT
D
Acetylated
-tubulin
A
_
+ +
_
MCF10a-H-ras
total cell lysate
MCF10a-H-ras
MT-fraction
E
0
20
40
60
80
A
ce
ty
la
t
e
d
 /T
ot
al
 tu
bu
li
n
(%
)
*
*
+ + + +- - - -
MCF10a
Neo
MCF10a
H-ras
10T1/2 10T1/2
H-ras
B
0
20
40
60
80
100
120
A
ct
iv
e
 e
rk
/ T
ot
a
l e
rk
 (
%
)
**
* *
Active erk 2
Active erk 1
erk 1 protein
erk 2 protein
ac
ti
ve
 e
rk
 1
ac
ti
ve
 e
rk
 1
ac
ti
ve
 e
rk
 1
ac
ti
ve
 e
rk
 1
ac
ti
ve
 e
rk
 2
ac
ti
ve
 e
rk
 2
ac
ti
ve
 e
rk
 2
ac
ti
ve
 e
rk
 2
Cellular erk MT-associ ated erk_ _+ +
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inhibition ( asterisks, P< .0007 and .0004 for active erk 1 and active erk 2 in cell lysates, respectively; P< .009 and .004 for active erk 1 and active erk 2 in MT -
enriched fractions, respectively ). (C ) Immunofluorescence of MCF10a -H - ras cells stained with the anti –acetylated  - tubulin antibody after treatment with DMSO
alone or 50 m PD 98059. An increase in acetylated MT levels was observed after inhibition of MKK1 (bar, 30 m). (D ) Levels of acetylated  - tubulin and total  -
tubulin in parental control, H - ras– transfected 10T1 / 2 and MCF10a cell lysates after treatment with PD 98059 or DMSO vehicle alone were assessed with Western
blot analysis. (E ) Densitometry of three independent Western blot analyses of acetylated  - tubulin levels, expressed as a percentage of total  - tubulin levels,
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treated cells. ( + ) denotes addition of 50 m PD98059, (  ) denotes DMSO carrier alone.
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levels in H-ras–transfected cells, parental and H-ras–
transfected 10T1/2 and MCF10a cells were treated with a
MKK1 inhibitor, PD 98059, or DMSO carrier vehicle alone.
The activity of total cellular and MT-bound erk 1 and 2 levels
were significantly and similarly reduced after acute treatment
with PD 98059, in the absence of detectable changes in the
expression of erk protein and in the absence of a decrease in
the association of erk with MTs in both ras- transfected
(Figure 6;A and B ) and parental cells (data not shown).
However, acetylated  - tubulin levels, detected both by
immunofluorescence and Western blot analyses, were
significantly increased in treated H-ras–transfected cells
(Figure 6;C  E ) but not in parental cells (Figure 6E ).
To confirm results with H-ras transfected cells treated
with PD 98059, 10T1/2-H-ras cells were transiently trans-
fected with an HA-tagged mutant of MKK 1 that functions as
a dominant negative inhibitor [41,42]. An increase in
acetylated MTs was detected in transfected cells, marked
by reactivity to an anti–HA- tag antibody (Figure 7; asterisk ).
Surrounding nontransfected cells (Figure 7, arrowheads ) did
not exhibit this increase in acetylated  - tubulin staining and
served as internal controls.
Discussion
Tumor progression involves enhanced cancer cell invasion
and proliferation, events that require MT reorganization,
which arises from a regulated but dynamic instability. Many
factors regulate MT stability but the most well studied is the
role of MAPs that promote MT stability and enhance turnover
when they are released from MTs as a result of phosphor-
ylation by an orchestra of kinases [6]. ERK kinases have
previously been shown to decorate both interphase and
mitotic spindle MTs [15–19] and this kinase family has also
been proposed to be one of the many kinase regulators of
MT stability, based primarily on their ability to phosphorylate
MAPs in vitro [14]. To our knowledge, we provide the first in
vivo evidence that activation of ERK1 and 2 is required for
destabilization of MTs in cells containing activated ras
signaling pathways. We show that H-ras–mediated activa-
tion of erk results in an increased association of activated erk
with MTs, noted previously by others [16], and that erk
activity mediates a significant amount of MT instability in two
cell backgrounds. Inhibition of erk kinase activity in H-ras
MCF10a breast cells restored MT stability, as detected by
acetylation of  - tubulin, to approximately 30% that of
parental breast epithelial cells. In contrast, inhibition of erk
kinase in H-ras-10T1/2 fibroblasts restored stability to
approximately 80% of parental 10T1/2 cells. In H-ras–
transfected breast cells, there must exist multiple additional
mechanisms that regulate MT stability whereas the erk
pathway is the predominant pathway for controlling MT in H-
ras–transfected fibroblasts. Possible alternative pathways
could include ras- regulated expression of proteins that
modify MT stability such as strathmin [26] and/or other
kinases that phosphorylate MAPs and that are activated by
ras [7]. Possibly, such additional pathways are restricted in
fibroblasts. In this context the kinetics of MT disassembly
have been reported to differ between fibroblasts and
epithelial cells [37].
Our results suggesting that erk only mediates MT stability
in cells expressing an activated ras could mean that other
pathways cooperate with erk kinases to effect MT turnover
that are not activated in the parental cells. At present, we
cannot exclude the possibility that  - tubulin subunits in
parental cells are maximally acetylated and any erk-
mediated changes in MT stability in parental cells are simply
not detected with this marker. Use of other assays of MT
stability such as recovery of MT polymers following a
nocodazole block could resolve these possibilities [37,38].
If parental and ras- transfected cells do indeed differ in their
reliance on erk for MT stability, the subset of erk kinases that
associate with MTs in tumor cells that either hyperexpress
ras or bear a mutant active ras, or other disease conditions
where ras is constitutively activated by inappropriate signal-
ing through cytokines/growth factors, might provide a useful
therapeutic target [5,39].
ERK kinases have primarily been studied for their role in
regulating activation of AP-1 transcription factors and
consequent regulation of genes involved in invasion and
motility, for instance specific metalloproteinases. This
property is consistent with the localization of activated erk
kinase to the cell nucleus in proliferating cells [21]. Several
recent reports, however, have noted the presence of
activated erk kinases in nonnuclear compartments including
focal adhesions [20], cell lamellae [40], and as we and
others [15–19] have noted, MTs. These observations and
the known ability of erk kinases to phosphorylate proteins
associated with the cytoskeleton including myosin light-
chain kinase [41] and MAPs raise important questions as to
the role of erk kinases in these additional cellular compart-
ments. The ability of erk kinases to phosphorylate MAPs in
vitro [6 ] provides support for the existence of an erk-
mediated mechanism of MT turnover that could be inde-
pendent of gene expression. The effect of erk kinases on MT
stability could contribute to the documented role of these
kinases in regulating cell motility, invasion, and proliferation
[21]. MTs serve as tracks for cellular transport and regulate
Figure 7. Transient transfection of a dominant negative HA- tagged MKK1
increases acetylated  - tubulin immunostaining in H - ras– transfected murine
10T1 /2 cells. (A and B ) Immunofluorescence of 10T1 /2 -H - ras cells with an
anti –HA epitope tag antibody (A, green ) and an anti –acetylated  - tubulin
antibody (A and B, red ), after transient transfection of an HA - tagged
dominant negative MKK cDNA. The asterisk indicates a transfected cell,
surrounded by untransfected cells ( arrowheads ). Pronounced acetylated
cytoplasmic MT arrays were observed only in transfected cells.
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cell shape, polarity, and cell process formation, all of which
are required functions for cell motility [4]. Mutant active H-
and K-ras promote MT reorganization within polarized active
lamellae and processes [42], whereas N-ras stimulates
MT-dependent particle translocation [43]. Decreased MT
stability is likely required for the rapid formation of extensions
and lamellae during migration and invasion, and for the
exocytosis of sequestered molecules important for invasion,
such as matrix metalloproteinases (MMPs). Enhanced MT
turnover is also required for targeting and promoting focal
adhesions involved in cell motility and growth responses [4].
MTs have also recently been reported to regulate the
formation of podosomes, which are located under the cell
body and which are sites of release for metalloproteinases
[44,45]. When podosomes are located at the tips of cell
protrusions, they promote cell motility and invasion [44,45].
Enhanced proliferation may be mediated by decreased MT
stability, as formation of the mitotic spindle requires an
estimated 20- to 100- fold decrease in MT stability of
interphase MTs [7].
Hyperexpression of erk and MKK have recently been
linked to the progression of human breast carcinoma. In
human tumor biopsies, the overexpression of MKK and erk 1
and 2 has been noted in breast cancer tumors [27–29]. As
well, human breast -cancer cells expressing H-ras exhibit up
to 15- fold enhanced erk activity and their anchorage-
independent growth is strongly inhibited by PD 98059 [32].
We confirm an enhanced activation of erk in breast cancer
cells and extend this to show an enhanced association of erk
with MTs. Previous reports have shown that erk decorates
MTs in NIH 3T3 fibroblasts, neurons, macrophages, and
mouse oocytes [15–19]. These results are extended here to
include human breast epithelial cells and 10T1/2 murine
fibroblasts.
Understanding the role of mutant ras in MT stability and
identifying accessory upstream or downstream proteins
associated with erk activation may ultimately permit the
development of combination therapies and/or paclitaxel -
like drugs that exhibit enhanced efficacy and reduced
toxicity.
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